151 related articles for article (PubMed ID: 16399867)
1. The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway.
Fetalvero KM; Shyu M; Nomikos AP; Chiu YF; Wagner RJ; Powell RJ; Hwa J; Martin KA
Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1337-46. PubMed ID: 16399867
[TBL] [Abstract][Full Text] [Related]
2. Novel signaling pathways promote a paracrine wave of prostacyclin-induced vascular smooth muscle differentiation.
Kasza Z; Fetalvero KM; Ding M; Wagner RJ; Acs K; Guzman AK; Douville KL; Powell RJ; Hwa J; Martin KA
J Mol Cell Cardiol; 2009 May; 46(5):682-94. PubMed ID: 19302827
[TBL] [Abstract][Full Text] [Related]
3. The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation.
Martin KA; Rzucidlo EM; Merenick BL; Fingar DC; Brown DJ; Wagner RJ; Powell RJ
Am J Physiol Cell Physiol; 2004 Mar; 286(3):C507-17. PubMed ID: 14592809
[TBL] [Abstract][Full Text] [Related]
4. The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell migration via exchange protein directly activated by cAMP.
McKean JS; Murray F; Gibson G; Shewan DA; Tucker SJ; Nixon GF
Cardiovasc Res; 2015 Sep; 107(4):546-55. PubMed ID: 26092100
[TBL] [Abstract][Full Text] [Related]
5. Gbetagamma-mediated prostacyclin production and cAMP-dependent protein kinase activation by endothelin-1 promotes vascular smooth muscle cell hypertrophy through inhibition of glycogen synthase kinase-3.
Taurin S; Hogarth K; Sandbo N; Yau DM; Dulin NO
J Biol Chem; 2007 Jul; 282(27):19518-25. PubMed ID: 17513863
[TBL] [Abstract][Full Text] [Related]
6. Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway.
Mottola G; Chatterjee A; Wu B; Chen M; Conte MS
PLoS One; 2017; 12(3):e0174936. PubMed ID: 28362840
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation.
Li Y; Connolly M; Nagaraj C; Tang B; Bálint Z; Popper H; Smolle-Juettner FM; Lindenmann J; Kwapiszewska G; Aaronson PI; Wohlkoenig C; Leithner K; Olschewski H; Olschewski A
Am J Respir Cell Mol Biol; 2012 Mar; 46(3):372-9. PubMed ID: 22021335
[TBL] [Abstract][Full Text] [Related]
8. Prostacyclin induces apoptosis of vascular smooth muscle cells by a cAMP-mediated inhibition of extracellular signal-regulated kinase activity and can counteract the mitogenic activity of endothelin-1 or basic fibroblast growth factor.
Li RC; Cindrova-Davies T; Skepper JN; Sellers LA
Circ Res; 2004 Apr; 94(6):759-67. PubMed ID: 14963006
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional inhibition of protease-activated receptor-1 expression by prostacyclin in human vascular smooth muscle cells.
Pape R; Rauch BH; Rosenkranz AC; Kaber G; Schrör K
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):534-40. PubMed ID: 18162607
[TBL] [Abstract][Full Text] [Related]
10. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Egr1 expression underlies the anti-mitogenic effects of cAMP in vascular smooth muscle cells.
Kimura TE; Duggirala A; Hindmarch CC; Hewer RC; Cui MZ; Newby AC; Bond M
J Mol Cell Cardiol; 2014 Jul; 72(100):9-19. PubMed ID: 24534707
[TBL] [Abstract][Full Text] [Related]
12. mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors.
Hegner B; Lange M; Kusch A; Essin K; Sezer O; Schulze-Lohoff E; Luft FC; Gollasch M; Dragun D
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):232-8. PubMed ID: 19074484
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective prostacyclin signaling in vascular smooth muscle.
Fetalvero KM; Martin KA; Hwa J
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):109-18. PubMed ID: 17164138
[TBL] [Abstract][Full Text] [Related]
14. Dual role of PKA in phenotypic modulation of vascular smooth muscle cells by extracellular ATP.
Hogarth DK; Sandbo N; Taurin S; Kolenko V; Miano JM; Dulin NO
Am J Physiol Cell Physiol; 2004 Aug; 287(2):C449-56. PubMed ID: 15238360
[TBL] [Abstract][Full Text] [Related]
15. AMP-Activated Protein Kinase Alpha 2 Deletion Induces VSMC Phenotypic Switching and Reduces Features of Atherosclerotic Plaque Stability.
Ding Y; Zhang M; Zhang W; Lu Q; Cai Z; Song P; Okon IS; Xiao L; Zou MH
Circ Res; 2016 Sep; 119(6):718-30. PubMed ID: 27439892
[TBL] [Abstract][Full Text] [Related]
16. Prostacyclin facilitates vascular smooth muscle cell phenotypic transformation via activating TP receptors when IP receptors are deficient.
Li Z; Luo W; Fang S; Chen X; Lin T; Zhou S; Zhang L; Yang W; Li Z; Ye J; Wang J; Liu P; Li Z
Acta Physiol (Oxf); 2021 Feb; 231(2):e13555. PubMed ID: 32886850
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation.
Brown DJ; Rzucidlo EM; Merenick BL; Wagner RJ; Martin KA; Powell RJ
J Vasc Surg; 2005 Mar; 41(3):509-16. PubMed ID: 15838487
[TBL] [Abstract][Full Text] [Related]
18. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
19. Cilostazol promotes vascular smooth muscles cell differentiation through the cAMP response element-binding protein-dependent pathway.
Chen WJ; Chen YH; Lin KH; Ting CH; Yeh YH
Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2106-13. PubMed ID: 21680899
[TBL] [Abstract][Full Text] [Related]
20. The early- and late stages in phenotypic modulation of vascular smooth muscle cells: differential roles for lysophosphatidic acid.
Guo H; Makarova N; Cheng Y; E S; Ji RR; Zhang C; Farrar P; Tigyi G
Biochim Biophys Acta; 2008 Sep; 1781(9):571-81. PubMed ID: 18602022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
